Matches in Wikidata for { <http://www.wikidata.org/entity/Q74278523> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q74278523 description "clinical trial" @default.
- Q74278523 description "ensayu clínicu" @default.
- Q74278523 description "klinisch onderzoek" @default.
- Q74278523 description "клінічне випробування" @default.
- Q74278523 name "Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas" @default.
- Q74278523 name "Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas" @default.
- Q74278523 type Item @default.
- Q74278523 label "Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas" @default.
- Q74278523 label "Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas" @default.
- Q74278523 prefLabel "Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas" @default.
- Q74278523 prefLabel "Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas" @default.
- Q74278523 P1050 Q74278523-92C16862-1531-48C6-8FAB-E3D6C1105E16 @default.
- Q74278523 P1132 Q74278523-031F323B-74E7-44A3-8984-27A32BBAC483 @default.
- Q74278523 P1476 Q74278523-B9F0B992-6195-40E4-ADBA-B7A9B09BA0EA @default.
- Q74278523 P17 Q74278523-DF22B5B8-C0FF-4394-B96F-B8FC03D6907C @default.
- Q74278523 P1813 Q74278523-7C35E4B5-4902-4112-84B5-461E8680B218 @default.
- Q74278523 P2899 Q74278523-132C69F1-7D5B-4830-8F52-45031522531F @default.
- Q74278523 P3098 Q74278523-6AFB473F-AFB4-4269-BDCA-94466EE3D5C9 @default.
- Q74278523 P31 Q74278523-1B43513B-19BA-4A95-8FD0-B5924F133452 @default.
- Q74278523 P580 Q74278523-4152FB86-3906-470A-8F03-E1AE0C376307 @default.
- Q74278523 P582 Q74278523-3E4328F6-4997-407E-8E8B-6366AF2E2B61 @default.
- Q74278523 P6099 Q74278523-F83679CA-A441-49A5-8D97-8BCCAA6729B6 @default.
- Q74278523 P8363 Q74278523-0A5609BE-E58F-4036-841F-DB3343173EE3 @default.
- Q74278523 P1050 Q33525 @default.
- Q74278523 P1132 "+25" @default.
- Q74278523 P1476 "A Phase II Single Arm Trial Evaluating the Efficacy and Safety of Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas Progressing After First-Line Platinum- Based Therapy" @default.
- Q74278523 P17 Q38 @default.
- Q74278523 P1813 "TENEC" @default.
- Q74278523 P2899 "+18" @default.
- Q74278523 P3098 "NCT04122911" @default.
- Q74278523 P31 Q30612 @default.
- Q74278523 P580 "2017-01-29T00:00:00Z" @default.
- Q74278523 P582 "2017-12-30T00:00:00Z" @default.
- Q74278523 P6099 Q42824440 @default.
- Q74278523 P8363 Q78089383 @default.